Evidence map›Paper›PMID 24055376›Full record

ArticleJournal of molecular biology2014

The N-terminal sequence of tyrosine hydroxylase is a conformationally versatile motif that binds 14-3-3 proteins and membranes.

Age Aleksander Skjevik, Mauro Mileni, Anne Baumann, Oyvind Halskau, Knut Teigen, Raymond C Stevens, Aurora Martinez

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Frontiers in genetics · 2021
    Article
  8. Article
  9. Article
  10. Structural basis of O-GlcNAc recognition by mammalian 14-3-3 proteins.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  11. Review
  12. De Novo Mutations in YWHAG Cause Early-Onset Epilepsy.American journal of human genetics · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Complex molecular regulation of tyrosine hydroxylase.Journal of neural transmission (Vienna, Austria : 1996) · 2014
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Age Aleksander SkjevikDepartment of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway.
Mauro MileniDepartment of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Anne BaumannDepartment of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway.
Oyvind HalskauDepartment of Molecular Biology, University of Bergen, Thormøhlensgate 55, N-5020 Bergen, Norway.
Knut TeigenDepartment of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway.
Raymond C StevensDepartment of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Aurora MartinezDepartment of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway. Electronic address: aurora.martinez@biomed.uib.no.
University of Bergen · NOScripps Research Institute · US

Funding

JCSG Center:Innovative Membrane Protein Technology (RMI)P50GM073197 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI STEVENS, RAYMOND C · 2004 to 2013
$26.8M
NIGMS NIH HHS GM073197NIGMS NIH HHS P50 GM073197
6 · The paper itself

Abstract

Tyrosine hydroxylase (TH) catalyzes the rate-limiting step in the synthesis of catecholamine neurotransmitters, and a reduction in TH activity is associated with several neurological diseases. Human TH is regulated, among other mechanisms, by Ser19-phosphorylation-dependent interaction with 14-3-3 proteins. The N-terminal sequence (residues 1-43), which corresponds to an extension to the TH regulatory domain, also interacts with negatively charged membranes. By using X-ray crystallography together with molecular dynamics simulations and structural bioinformatics analysis, we have probed the conformations of the Ser19-phosphorylated N-terminal peptide [THp-(1-43)] bound to 14-3-3γ, free in solution and bound to a phospholipid bilayer, and of the unphosphorylated peptide TH-(1-43) both free and bilayer bound. As seen in the crystal structure of THp-(1-43) complexed with 14-3-3γ, the region surrounding pSer19 adopts an extended conformation in the bound state, whereas THp-(1-43) adopts a bent conformation when free in solution, with higher content of secondary structure and higher number of internal hydrogen bonds. TH-(1-43) in solution presents the highest mobility and least defined structure of all forms studied, and it shows an energetically more favorable interaction with membranes relative to THp-(1-43). Cationic residues, notably Arg15 and Arg16, which are the recognition sites of the kinases phosphorylating at Ser19, are also contributing to the interaction with the membrane. Our results reveal the structural flexibility of this region of TH, in accordance with the functional versatility and conformational adaptation to different partners. Furthermore, this structural information has potential relevance for the development of therapeutics for neurodegenerative disorders, through modulation of TH-partner interactions.

Indexed as

14-3-3 ProteinsCrystallography, X-RayHumansMembranesMolecular Dynamics SimulationProtein BindingProtein ConformationTyrosine 3-Monooxygenase14-3-3 ProteinsTyrosine 3-Monooxygenasefree energy of bindingMDMM/PBSAmolecular dynamicsmolecular dynamics simulationsmolecular mechanics Poisson–Boltzmann surface areapalmitoyl-oleoyl phosphatidylserinePCphosphatidylcholinephospholipid bilayersphosphorylationPOPSresponse unitsRUSPRsurface plasmon resonanceTHtyrosine hydroxylaseX-ray crystallography

Identifiers

PMID24055376
PMCPMC3872242
OpenAlexW2094295346

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.